Publications
361
Citations
10,508
Est. group size
~37
Recurring co-author estimate
Active years
50
Publishing since 1976
Floor Backes conducts clinical and translational research in gynecologic oncology, focusing on cancers of the ovary, endometrium (uterine lining), and cervix. Their work spans clinical trials of targeted therapies and immunotherapies (such as PARP inhibitors, lenvatinib/pembrolizumab combinations, and cyclin-targeted drugs), biomarker studies for predicting treatment response, and real-world outcomes research examining treatment patterns, cost, and disparities in cancer care. This research is aimed at improving treatment selection and outcomes for patients with gynecologic cancers.
Publication output has grown substantially over the last decade, particularly since 2022, with output nearly doubling compared to earlier years in the period.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)
Gynecologic Oncology · 2025
- Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026)
Journal of Clinical Oncology · 2025
- Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study
International Journal of Gynecological Cancer · 2025
- Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
Gynecologic Oncology · 2025
- Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
Gynecologic Oncology · 2025
- Cyclin E1 as a predictive biomarker of azenosertib benefit in platinum-resistant ovarian cancer: Outcomes from part 1b of the DENALI study (GOG-3066)
Gynecologic Oncology · 2025
- Circulating extracellular vesicles protein expression for early prediction of platinum-resistance in high-grade serous ovarian cancer
Oncogene · 2025
- Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)
Gynecologic Oncology · 2025
- Immunotherapy-associated capillary leak syndrome in endometrial cancer: a case report and review of the literature
Gynecologic Oncology Reports · 2025
- Hyperthermic Intraperitoneal Chemotherapy in the Management of Ovarian, Fallopian Tube and Peritoneal Carcinomas
Surgical Oncology Clinics of North America · 2025
- Pembrolizumab Or Placebo Plus Adjuvant Chemotherapy With Or Without Radiotherapy In Patients With Newly Diagnosed, High-Risk Endometrial Cancer: Exploratory Analysis Of Disease-Specific Survival From The Phase 3 ENGOT-En11/GOG-3053/KEYNOTE-B21 Study
International Journal of Gynecological Cancer · 2025
- Abstract CT071: Phase I trial of trastuzumab deruxtecan in combination with neratinib in solid tumors with HER2 alterations (NCI 10495)
Cancer Research · 2025
- Updated Patient-Reported Outcomes In The PRIMA/ENGOT-OV26/GOG-3012 Trial Of Niraparib First-Line Maintenance Therapy In Patients With Newly Diagnosed Advanced Ovarian Cancer
International Journal of Gynecological Cancer · 2025
- Defining “enlarged” sentinel lymph nodes in the setting of endometrial cancer: What is the size cut-off?
Gynecologic Oncology · 2025
- Abstract 429: Targeting translesion synthesis to sensitize ovarian cancer cells to PARP inhibitor treatment
Cancer Research · 2025
- Gynecologic Oncology×136
- International Journal of Gynecological Cancer×24
- Journal of Clinical Oncology×17
- Gynecologic Oncology Reports×13
- Annals of Oncology×9
- Paulina Haight
Medicine · The Ohio State University
- David E. Cohn
Medicine · The Ohio State University
- Kristin Bixel
Medicine · The Ohio State University
- Jessica Velasquez
Medicine · The Ohio State University
- Casey Cosgrove
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile